International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)

American Journal of Clinical Pathology

Volumn 111, Issue 4, 1999, Pages 507-513

  Savige, Judy ^a   Gillis, David ^b   Benson, Elizabeth ^b   Davies, David ^b   Esnault, Vincent ^b   Falk, Ronald J ^b   Hagen, E Chris ^b   Jayne, David ^b   Jennette, J Charles ^b   Paspaliaris, Bill ^b   Pollock, Wendy ^b   Pusey, Charles ^b   Savage, Caroline O S ^b   Silvestrini, Roger ^b   Van Der Woude, Fokko ^b   Wieslander, Jorgen ^b   Wiik, Allan ^b  

^a AUSTIN HEALTH   (Australia)

^b NONE

Author keywords

ANCA; Autoantibodies; Glomerulonephritis; Vasculitis

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; INTERNATIONAL COOPERATION; PRIORITY JOURNAL; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0033037938     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/111.4.507     Document Type: Article

References (48)

1. van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985;1:425-429.
2. Savage CO, Winearls CG, Jones S, et al. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet. 1987;1:1389-1393.
3. Falk RJ, Jennette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis. N Engl J Med. 1988;318;1651-1657.
4. Gross WL, Schmitt WH, Csernok E. Antineutrophil cytoplasmic autoantibody-associated disease: a rheumatologist's perspective. Am J Kidney Dis. 1991;28:175-179.
5. Cohen Tervaert JW, van der Woude FJ, Fauci AS, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med. 1989;149:2461-2465.
6. Jayne DRW, Gaskin G, Pusey CD, et al. ANCA and predicting relapse in systemic vasculitis. QJM. 1995;88:127-133.
7. DeRemee RA. Antineutrophil cytoplasmic autoantibody-associated diseases: a pulmonologist's perspective. Am J Kidney Dis. 1991;28:180-183.
8. Hagen C. Standardisation of solid phase assays for ANCA determination. Nephrology. 1997;3(suppl):S764-S765.
9. Jennette JC. Antineutrophil cytoplasmic autoantibody-associated diseases: a pathologist's perspective. Am J Kidney Dis. 1991;28:164-170.
10. Hagen EC, Andrassy K, Csernok E, et al. The value of indirect immunofluorescence and solid phase techniques for ANCA detection: a report on the first phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods. 1993;159:1-16.
11. Hagen EC, Andrassy K, Csernok E, et al. Development of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA): a report on the second phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods. 1996;196:1-15.
12. Hagen EC, Daha MR, Hermans J, et al. The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis: results of an international collaborative study. Kidney Int. 1998;53:743-753.
13. Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest. 1989;84:1577-1587.
14. Miles JL, McCluskey RT, Ahmad MF, et al. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood. 1989;74:1888-1893.
15. Lock RJ. Detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol. 1994;47:4-8.
16. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-192.
17. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101-1107.
18. Goeken JA. Antineutrophil cytoplasmic antibody: a useful serological marker for vasculitis. J Clin Immunol. 1991;11:161-174.
19. Mallon D, Silvestrini R, Benson E. Clinical findings in patients with positive cytoplasmic ANCA by indirect immunofluorescence with negative ELISA for proteinase 3 [abstract]. Nephrology. 1997:3(suppl):S792.
20. Wong RCW, Silvestrini RA, Savige J, et al. How the reporting of cANCA immunofluorescence patterns can be improved in Australasia [abstract]. Nephrology. 1997;3(suppl):S792.
21. Savige JA, Paspaliarais B, Silvestrini R, et al. A review of the immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J Clin Pathol. 1998;51:568-575.
22. Stroncek DF, Egging MS, Eiber GA, et al. Neutrophil alloantibodies react with cytoplasmic antigens as possible cause of false-positive indirect immunofluorescence assays for antibodies to neutrophil cytoplasmic antigens. Am J Kidney Dis. 1993;21:368-373.
23. Segelmark M, Baslund B, Wieslander J. Some patients with antimyeloperoxidase antibodies have a cANCA pattern. Clin Exp Immunol. 1994;96:458-465.
24. Yang JJ, Tuttle R, Falk RJ, et al. Frequency of anti-bactericidal/permeability-increasing protein (BPI) and anti-azurocidin in patients with renal disease. Clin Exp Immunol. 1996;105:125-131.
25. Snook JA, Chapman RW, Fleming K, et al. Antineutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol. 1989;76:30-33.
26. Saxon A, Shanahan F, Landers C, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86:202-210.
27. Bansi DS, Cameron BJ, Zhao M, et al. Antigen specificity of antineutrophil antibodies in ulcerative colitis, primary sclerosing cholangitis and autoimmune hepatitis [abstract]. Sarcoidosis Vasc Diffuse Lung Dis. 1996;205:278.
28. Savige JA, Gallichio MC, Stockman A, et al. Antineutrophil cytoplasm antibodies in rheumatoid arthritis. Clin Exp Immunol. 1991;86:92-98.
29. Nassberger L, Jonsson H, Sjoholm AG, et al. Circulating antielastase in systemic erythematosus. Lancet. 1989;I:509.
30. Wiik A. Granulocyte-specific antinuclear antibodies: possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy. 1980;35:263-289.
31. Dolman KM, Gans ROB, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993;342:651-652.
32. Short AK, Lockwood CM. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. QJM. 1995;88:775-783.
33. Moodie FDL, Leaker B, Cambridge G, et al. Alpha enolase: a novel cytosolic autoantigen in ANCA positive vasculitis. Kidney Int. 1993;43:675-681.
34. Roozendahl C, Zhao MH, Horst G, et al. Catalase and αenolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol. 1998;112:10-16.
35. Sobajima J, Ozaki S, Osakada F, et al. Novel autoantigens of perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: novel non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol. 1997;107:135-140.
36. Orth T, Gerken G, Kellner R, et al. Actin is a target antigen of antineutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type 1. J Hepatol. 1997;26:37-47.
37. Halbwechs-Mecarelli L, Nusbaum P, Noel LH, et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol. 1992;90:79-84.
38. Thomson RA, Lee SS. Antineutrophil cytoplasmic antibodies. Lancet. 1989;1:670-671.
39. Schmitt WH, Csernok E, Flesch BK, et al. Autoantibodies directed against lysozyme: a new target antigen for antineutrophil cytoplasmic antibodies. In: Gross WL, ed. ANCA-Associated Vasculitides: Immunological and Clinical Aspects. New York, NY: Plenum Press; 1993:256-271.
40. Brimnes J, Halberg P, Jacobsen S, et al. Specificities of antineutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin Exp Immunol. 1997;110:250-256.
41. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl. 1989;6:12-13.
42. Wiik A, Rasmussen N, Wieslander J. Methods to detect autoantibodies to neutrophilic granulocytes. In: van Venrooij WJ, Maini RN, eds. Manual of Biological Markers of Disease. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1993:1-14.
43. Wiik A. Antinuclear factors in sera from healthy blood donors. Acta Pathol Microbiol Scand. 1976;84:215-220.
44. Jennette JC, Wilkman AS, Falk RJ. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol. 1989;135:921-930.
45. Audrain MAP, Baranger TAR, Martin SJ, et al. Antinative and recombinant myeloperoxidase monoclonal and human autoantibodies [abstract]. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13;257.
46. Westman KWA, Bygren PG, Eilert I, et al. Rapid screening assay for anti-GBM antibody and ANCAs: an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol Dial Transplant. 1997;12:1863-1868.
47. Niles JL, Bottinger EP, Saurina GR, et al. The syndrome of lung haemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med. 1996;156:440-445.
48. Jayne DRW, Marshall PD, Jones SJ, et al. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990;37:965-970.